Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAIL
1401
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $10.7M | 0.01% |
+454,500
| New | +$9.94M |
|
|
FONR
1402
DELISTED
Fonar
FONR
| $10.7M | 0.01% |
544,716
+13,064
| +2% | +$262K |
|
|
LUNA
1403
DELISTED
Luna Innovations Incorporated
LUNA
| $10.7M | 0.01% |
1,471,207
-41,300
| -3% | -$272K |
|
|
AEGN
1404
DELISTED
Aegion Corp
AEGN
| $10.7M | 0.01% |
478,900
+15,400
| +3% | +$333K |
|
|
LGF.B
1405
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $10.7M | 0.01% |
1,077,493
+469,000
| +77% | +$4.05M |
|
|
IMMU
1406
DELISTED
Immunomedics Inc
IMMU
| $10.7M | 0.01% |
+505,302
| New | +$8.91M |
|
1407
Columbus McKinnon
CMCO
$548M
| $10.6M | 0.01% |
266,000
+25,700
| +11% | +$994K |
|
1408
Adobe
ADBE
$105B
| $10.6M | 0.01% |
32,233
-21,800
| -40% | -$6.41M |
|
1409
Zurn Elkay Water Solutions
ZWS
$8.4B
| $10.6M | 0.01% |
674,270
-50,032
| -7% | -$720K |
|
|
BRFS
1410
DELISTED
BRF SA
BRFS
| $10.6M | 0.01% |
1,216,453
+646,893
| +114% | +$5.58M |
|
1411
NXP Semiconductors
NXPI
$58.7B
| $10.6M | 0.01% |
+83,087
| New | +$9.64M |
|
1412
Federal Signal
FSS
$7.71B
| $10.6M | 0.01% |
327,300
+117,200
| +56% | +$3.82M |
|
1413
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $10.5M | 0.01% |
167,400
-60,600
| -27% | -$3.73M |
|
1414
AtriCure
ATRC
$2.23B
| $10.5M | 0.01% |
323,200
+115,700
| +56% | +$3.29M |
|
1415
AngioDynamics
ANGO
$647M
| $10.5M | 0.01% |
655,214
+149,268
| +30% | +$2.28M |
|
1416
Graham Corp
GHM
$1.3B
| $10.5M | 0.01% |
479,396
+9,417
| +2% | +$203K |
|
1417
Chord Energy
CHRD
$7.49B
| $10.5M | 0.01% |
+3,214,631
| New | +$9.2M |
|
|
MTSC
1418
DELISTED
MTS Systems Corp
MTSC
| $10.5M | 0.01% |
217,900
-23,318
| -10% | -$1.24M |
|
1419
The Bancorp
TBBK
$2.84B
| $10.4M | 0.01% |
805,672
-1,628
| -0.2% | -$18.3K |
|
1420
Gorman-Rupp
GRC
$2.13B
| $10.4M | 0.01% |
278,115
+44,100
| +19% | +$1.61M |
|
|
IBKC
1421
DELISTED
IBERIABANK Corp
IBKC
| $10.4M | 0.01% |
138,948
+21,500
| +18% | +$1.6M |
|
1422
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $10.4M | 0.01% |
97,255
+68,012
| +233% | +$7.25M |
|
1423
Glaukos
GKOS
$11B
| $10.4M | 0.01% |
190,292
-73,808
| -28% | -$4.49M |
|
|
HI
1424
DELISTED
Hillenbrand
HI
| $10.3M | 0.01% |
310,520
-263,080
| -46% | -$8.31M |
|
|
FFNW
1425
DELISTED
First Financial Northwest, Inc
FFNW
| $10.3M | 0.01% |
692,200
+17,206
| +3% | +$249K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.